Efficacy of methyldopa versus nifedipine in mild and severe pregnancy induced hypertension

Sopanrao Malharrao Togarikar


Background: Hypertension and its associated disorders are major health concerns during pregnancy. Antihypertensive therapy prescribes, when blood pressure is >140/90 mm of Hg, to minimize elevated blood pressure. The present study aimed to assess the efficacy of nifedipine and methyldopa in the antihypertensive treatment of mild and severe pregnancy induced hypertension (PIH).

Methods: A total one hundred Patients attending antenatal clinic of the department between 26-37 weeks of gestation suffering from PIH were recruited. Participants were divided in to two groups i.e. group-I consists of 50 patients medicated with oral methyldopa and group-II consists of 50 patients treated with Nifedipine 10mg.

Results: Methyldopa reduced systolic blood pressure (SBP) from 162±19.6 to 140.3±10.01 and diastolic blood pressure (DBP) from 99.6±8.8 to 96.17±6.4. Nifedipine reduced SBP from 99.6±8.8 to 96.17±6.4 and DBP from 99.2± 7.4 to 93.45±12.3. Response to methyldopa and nifedipine was almost similar in mild PIH but in severe PIH, 65.5% of patients required additional drug atenolol for adequate control of PIH.

Conclusions: Methyldopa and nifedipine are effective drugs for lowering blood pressure when given orally, Methyldopa was found to have a higher incidence of Intra uterine growth restriction while nifedipine was found to have an increased incidence of perinatal mortality.


Diastolic blood pressure, Methyldopa, Nifedipine, Pregnancy induced hypertension, Proteinuria, Systolic blood pressure

Full Text:



Kaunitz AM, Hughes JM, Grimes DA, Smith JC, Rochat RW, Kafrissen ME. Causes of maternal mortality in the United States. Obstet Gynecol. 1985 May 1;65(5):605-12.

Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 1988;158:892-8.

Gifford RW, August PA, Cunningham G. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183:1-22.

Krauss T, Kuhn W, Lakoma C. Circulating endothelial adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol. 1997;177: 439-443.

Giannubilo SR, Bezzeccheri V, Cecchi S, Landi B, Battistoni GI. Nifedipine versus labetalol in the treatment of hypertensive disorders of pregnancy. Arch Gynecol Obstet. 2012;286:637-42.

Margaard S, Forman A, Anderson KE. Effect of Nifedipine on human placental artries. Gynaecol Obstet Investig. 1984;18:217-24.

Abalos E, Duley L, Steyn DW, Henderson-smart DJ. Antihypertensive drug therapy to mild to moderate hypertension during pregnancy. Cochrane Library. 2003;1.

Cvijic M, Horvat M, Jernejcic P, Verdenik I, Geršak K. Analysis of the intake of drugs used in hypertensive disorders during pregnancy. Zdrav Vestn. 2010;79:412-8.

Zibaeenazhad MJ, M Ghodsi P Arab, Gholzom N. the prevalence of hypertensive disorders of pregnancy in Shiraz, Southern Iran. Iranian Cardiovascular Res J. 2010;4:169-72.

Redman CWG, Gallery ED, Mitchell MD. Fall in BP in response to volume expansion in pregnancy associated hypertension (PE): Why does it occur? BMJ. 1984;2(2):177-82.

Lardoux H, Blazquez G, Leperlier E, Gérard J. Randomized, comparative study on the treatment of moderate arterial hypertension during pregnancy: methyldopa, acebutolol, labetalol. Arch Mal Coeur Vaiss. 1988;81:137-40.

Sibai BM, Barton JR, Sherif AKL, Sarinoglu C, Mercer BM. A randomized prospective comparison of nifedipine and bed rest versus bed rest alone in the management of preeclampsia remote from term. Am J Obstet Gynecol. 1992;167:879-84.

Bharathi KN, Prasad KVSRG, Jagannath P, Nalini KS. Comparison of Nifedipine with Methyldopa for Control of Blood Pressure in Mild to Moderate Pregnancy Induced Hypertension. J Clin Diagnos Res. 2010;4(3):2406-9.

Jayasutha J, Ismail AM, Senthamarai R. Evaluation on efficacy of Methyldopa monotherapy and combination therapy with Nifedipine in pregnancy-induced hypertension. Der Pharmacia Lettre. 2011;3:383-7.

Vidyadhar B, Giri P, Gavhane SP. A study to compare the efficacy of low dose magnesium sulphate (Dhaka) regime with Pritchard regime in eclampsia. Int J Biomed Adv Res. 2012;03(01):53-58.

Redman CWG, Berlin IJ, Bonnar J, Ounsted MK. Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet. 1976 Oct 9;2(7989):753-6.

Seshadri L, Venkataraman I. Hypertension in Pregnancy Outcomes, Proteinuric vs. Nonproteinuric. J Reprod Med. 1997;42(2):88-90.

Ismail AAA, Medhat I, Tawfic TAS, Kholeif A. Int J Gynecol Obstet. 1993;1:39-43.